ATE425767T1 - Konjugate von cyanovirin-varianten und einem polyalkylenoxid - Google Patents

Konjugate von cyanovirin-varianten und einem polyalkylenoxid

Info

Publication number
ATE425767T1
ATE425767T1 AT03813787T AT03813787T ATE425767T1 AT E425767 T1 ATE425767 T1 AT E425767T1 AT 03813787 T AT03813787 T AT 03813787T AT 03813787 T AT03813787 T AT 03813787T AT E425767 T1 ATE425767 T1 AT E425767T1
Authority
AT
Austria
Prior art keywords
cyanovirin
conjugates
variants
polyalkylene oxide
water
Prior art date
Application number
AT03813787T
Other languages
English (en)
Inventor
M Snell
Michael Roberts
Toshiyuki Mori
Barry O'keefe
Michael Boyd
Original Assignee
Nektar Therapeutics Al Corp
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp, Us Gov Health & Human Serv filed Critical Nektar Therapeutics Al Corp
Application granted granted Critical
Publication of ATE425767T1 publication Critical patent/ATE425767T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyethers (AREA)
AT03813787T 2002-12-19 2003-12-18 Konjugate von cyanovirin-varianten und einem polyalkylenoxid ATE425767T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43595002P 2002-12-19 2002-12-19
US46173103P 2003-04-09 2003-04-09

Publications (1)

Publication Number Publication Date
ATE425767T1 true ATE425767T1 (de) 2009-04-15

Family

ID=32685420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03813787T ATE425767T1 (de) 2002-12-19 2003-12-18 Konjugate von cyanovirin-varianten und einem polyalkylenoxid

Country Status (10)

Country Link
US (2) US7267941B2 (de)
EP (1) EP1620129B1 (de)
JP (2) JP2006517400A (de)
KR (1) KR101145990B1 (de)
AT (1) ATE425767T1 (de)
AU (1) AU2003301122B2 (de)
CA (1) CA2507904C (de)
DE (1) DE60326774D1 (de)
MX (1) MXPA05006688A (de)
WO (1) WO2004056852A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006688A (es) * 2002-12-19 2006-02-22 Nektar Therapeutics Al Corp Conjugados de polimero con una variante de cianovirina.
US7432331B2 (en) 2002-12-31 2008-10-07 Nektar Therapeutics Al, Corporation Hydrolytically stable maleimide-terminated polymers
WO2007037245A1 (ja) * 2005-09-29 2007-04-05 Shionogi & Co., Ltd. 血管新生抑制作用を有するポリペプチド
WO2008019214A1 (en) 2006-08-04 2008-02-14 Prolong Pharmaceuticals, Inc. Modified erythropoietin
EP2051730B1 (de) * 2006-08-18 2011-11-02 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin
MX2009002820A (es) 2006-09-15 2009-06-04 Creabilis Therapeutics Spa Conjugados polimericos de box-a de hmgb1 y variantes de box-a de hmgb1.
CN101143894A (zh) * 2007-06-22 2008-03-19 中国药科大学 高效抑制血管生成多肽及其物理化学修饰方法和应用
KR20170072365A (ko) 2007-12-27 2017-06-26 백스터 인터내셔널 인코포레이티드 생리학적으로 수용가능한 중합체 분자를 특이적으로 검출하기 위한 방법 및 조성물
KR101678925B1 (ko) 2008-06-30 2016-11-24 에스바테크 - 어 노바티스 컴파니 엘엘씨 기능화 폴리펩티드
JP5588983B2 (ja) 2008-08-11 2014-09-10 ウェルズ ファーゴ バンク ナショナル アソシエイション マルチアームポリマーアルカノエートコンジュゲート
KR101929641B1 (ko) 2008-10-17 2018-12-14 박스알타 인코퍼레이티드 낮은 수준의 수용성 중합체를 포함하는 개질된 혈액 인자
CA2740904C (en) 2008-10-21 2019-01-15 Baxter International Inc. Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation)
WO2011024748A1 (ja) * 2009-08-28 2011-03-03 一般財団法人化学及血清療法研究所 インフルエンザm2由来の改変ペプチドワクチン
CN101638435B (zh) * 2009-09-04 2011-11-16 暨南大学 一种蓝藻病毒蛋白n突变体、其修饰衍生物及应用
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US20140088021A1 (en) 2011-05-27 2014-03-27 Nektar Therapeutics Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
CN104220097B (zh) * 2011-12-19 2019-08-09 建新公司 促甲状腺激素组合物
WO2019108656A1 (en) 2017-11-28 2019-06-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microbicidal composition
EP3731872B1 (de) 2017-12-29 2021-11-24 F. Hoffmann-La Roche AG Verfahren zur bereitstellung monopegylierten proteinen
EP3731873B1 (de) * 2017-12-29 2022-01-26 F. Hoffmann-La Roche AG Verfahren zur bereitstellung monopegylierter proteine
EP3731871B1 (de) * 2017-12-29 2023-10-04 F. Hoffmann-La Roche AG Verfahren zur bereitstellung pegylierter proteinen
CN116854785A (zh) * 2023-05-16 2023-10-10 青岛双元泰和药业有限公司 位点特异性修饰和标记的抗病毒肽氰病毒素n

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6780847B2 (en) * 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
JP2005516607A (ja) 2002-02-07 2005-06-09 デルタ バイオテクノロジー リミテッド Hiv阻害タンパク質
MXPA05006688A (es) * 2002-12-19 2006-02-22 Nektar Therapeutics Al Corp Conjugados de polimero con una variante de cianovirina.

Also Published As

Publication number Publication date
DE60326774D1 (de) 2009-04-30
US20040258706A1 (en) 2004-12-23
AU2003301122A1 (en) 2004-07-14
US7547509B2 (en) 2009-06-16
CA2507904C (en) 2014-12-02
JP2011050382A (ja) 2011-03-17
MXPA05006688A (es) 2006-02-22
KR20050084433A (ko) 2005-08-26
EP1620129B1 (de) 2009-03-18
JP2006517400A (ja) 2006-07-27
JP4903891B2 (ja) 2012-03-28
US7267941B2 (en) 2007-09-11
AU2003301122B2 (en) 2009-11-26
WO2004056852A3 (en) 2004-10-07
KR101145990B1 (ko) 2012-08-23
EP1620129A2 (de) 2006-02-01
US20080015151A1 (en) 2008-01-17
WO2004056852A2 (en) 2004-07-08
CA2507904A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
DE60326774D1 (de) Konjugate von cyanovirin-varianten und einem polyalkylenoxid
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
CY1116616T1 (el) Θεραπευτικη αγωγη ογκων του μαστου με παραγωγο ραπαμυκινης σε συνδυασμο με εξεμεστανη
ATE422880T1 (de) Heterofunktionelle copolymere von glycerol und polyethylenglykol, ihre konjugate und zusammensetzungen
DE50010132D1 (de) Wasserlösliche oder wasserquellbare Polymerisate
NO20052410D0 (no) Vannloselige jernkarbobydratkomplekser, produksjon derav og medikamenter inneholdende disse komplekser
MX2007005724A (es) Articulo para tratamiento cosmetico que comprende un sustrato y una composicion en gel.
DE502004010014D1 (de) Anionische ampholytische copolymere
NO20021862D0 (no) Katalysatorsammensetninger, fremgangsmåter for polymerisasjon og polymerer derfra
BR0210335A (pt) Copolìmero de blocos, e, composição
ATE377048T1 (de) Abbaubare polyacetal-polymere
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
DE60219677D1 (de) Wasserlösliche polymerkonjugate von retinoesäure
TW200722098A (en) Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in pharmaceutical compositions for treating cancer
BR0209440A (pt) Sulfonamidas
SE9904377D0 (sv) Pharmaceutical combinations
MXPA05011248A (es) Derivados de wortmanina solubles en agua.
MXPA05008099A (es) Productos n-aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
MA27889A1 (fr) Comprime contenant de la fluvastatine et de la carmellose calcique
DE60329397D1 (de) Tomatenprodukte
DE602004026747D1 (de) Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden
ATE319760T1 (de) Zusammensetzungen enthaltend endgruppen-verkappte polyalkylenglykole
DE60206940D1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
PT1244643E (pt) Inibidores da triptase
DE602004028236D1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties